chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Have been sick; Swelling on the face; Dizziness; Weakness; Headaches; Tiredness; Muscle pain; Chills; Joint pain; Nausea; Vomiting; Feeling unwell; Very decreased appetite; Diarrhea; Arm pain; Leg pain; Booster; This is a spontaneous report from a contactable consumer (Patient). A 79-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on 08Nov2021 in left arm, upper as dose 3 (booster), single for COVID-19 immunization. The patient medical history included Blood pressure high. Concomitant medication(s) included hydrochlorothiazide and losartan both taken for an unspecified indication, start and stop date were not reported. Previously patient received dose 1 and dose 2, COVID-19 Vaccine (Primary Immunization series completed but unknown manufacturer), Formulation: solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on unspecified date as dose 1, single and dose 2, single for COVID-19 immunization. No prior vaccinations within 4 weeks. Patient had received other unspecified products. Consumer stated, she had received her third Pfizer booster last Sunday (later clarified), 08Nov2021 and on unspecified date, patient experienced she have been sick all week long. On unspecified date, Patient experienced swelling on the face, dizziness and weakness, headaches, tiredness, muscle pain, chills, joint pain, nausea and vomiting, feeling unwell, very decreased appetite, diarrhea, arm pain, leg pain. Patient enquired how long, it is going to last like this. The patient did not received the treatment for the events, she had been in her house everyday and could not go out. The outcome for the events was unknown.  The lot number for vaccine [BNT162B2] was not provided and will be requested during follow-up.
Armpit is still swollen/ That got the lymph nodes; Armpit is painful/ Armpit hurts; Arm pain; Fatigue; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (Armpit is still swollen/ That got the lymph nodes), AXILLARY PAIN (Armpit is painful/ Armpit hurts), VACCINATION SITE PAIN (Arm pain) and FATIGUE (Fatigue) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 01L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Armpit is still swollen/ That got the lymph nodes), AXILLARY PAIN (Armpit is painful/ Armpit hurts), VACCINATION SITE PAIN (Arm pain) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Armpit is still swollen/ That got the lymph nodes) and AXILLARY PAIN (Armpit is painful/ Armpit hurts) had not resolved and VACCINATION SITE PAIN (Arm pain) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, Mammogram: normal (normal) normal, it was reported that patient's breast did not have anything.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter. Patient stated that they were instructed to not take anything so the vaccine could work.  Patient stated that she had No allergies and No history of COVID19. And also stated that she went to OB-GYN.   This case was linked to MOD-2022-482229 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Feb-2022: Follow up received contains no new information.
Patient felt she developed recurrence of fluctuating cognitive impairment that accompanied Covid infection. Developed over 2-3 weeks after each of her 3 vaccines (2 Pfizer and 1 Moderna)
Paresthesia of left arm, heaviness in both legs, paresthesia of toes. Left arm numbness and limited arm movement occurred immediately, paresthesia of toes and leg heaviness began within an hour of injection and worsened over 3-4 hours.
Severe stabbing pains and aches all over body; cramping of both feet; severe headache; loss of use of R arm (arm that was injected) for several hours; loss of energy; general malaise. Started about 7:30 PM after morning injection. Better now, but still have some overall body aches and pains,  headache, overall feeling like I'm getting over the flu. Continued pain in R armpit, R breast.
Bilateral arms flushed blanching red/pink color, most prominently in the proximal extremity. Bilateral dependent peripheral neuropathy in hands and feet. Bilateral ear tenderness.
Patient experienced nausea. Given water and snack. Patient left on her own after approx 25 minutes in the obs area.
Narrative:  COVID infection following COVID vaccine series 03/29, Moderna, dose #1 04/26, Moderna , dose #2 08/27 COVID swab, result:  detected 08/27 pt cc: exposure: unknown
No additional adverse effect; patient ws inadvertenly administeres a dose of VARIVAX, that had been improperly sored; This spontaneous report was received from the immunization coordinator concerning to a patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  On 04-DEC-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number S020464 with expiration date on 02-JUL-2021 (dosage schedule, route and anatomical location were not reported) for prophylaxis. The vaccine was reconstituted with a properly stored diluent.  Administered doses of vaccine experienced temperature excursion of -2.1 degrees Celsius (C)  for 4 hours and 30 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.
Client experienced tachycardia, palpitations and painful tightness in chest, throughout night of 03/01/2005.  Condition resolved, but now having similar symptoms when exerts.  Mild symptoms continue with exertion.  Client plans evaluation via cardiologist ASAP. Follow up03/09/05: Health department received called from patient who stated he had seen his cardiologist on 03/07/05. A diagnosis of pleurisy was made and that most likely it was caused by the vaccines administered on 02/28/05. A cardiac work up was not done in spite of patient's medical history. Indomethacin was prescribed and doctor feels that his condition has improved. The cardiologist does not consider a follow up appointment with him is indicated.
Patient described feeling hardness under the skin and redness/bruising at the injection site. Patient said he was not experiencing any pain or itchiness. He did see a doctor and was prescriber Keflex but the patient could not tell us what his diagnosis was.
Side effects; Minor allergic reaction; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Sep-2021 and was forwarded to Moderna on 17-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) and ALLERGY TO VACCINE (Minor allergic reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects) and ALLERGY TO VACCINE (Minor allergic reaction). At the time of the report, VACCINATION COMPLICATION (Side effects) and ALLERGY TO VACCINE (Minor allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant products were reported. No Treatment medication were reported.
Patient with history of lung cancer in remission. She was seen in the ED on 10/30 with cough, shortness of breath, fatigue, and sore throat.  She was tested for COVID in the ED by PCR and was positive. Patient was admitted from 10/30 - 11/1 with RLL pneumonia, COVID-19, and acute hypoxic respiratory failure.  She was initially on 3L O2 but was able to be weaned down to room air. She was discharged home. Patient has received the primary COVID vaccine series and two boosters.
Patient was given an IM shot of DTaP (4th dose too early). No symptoms at time of vaccine administration. Was seen an hour after vaccine was given and remained asymptomatic.
Administered just prior to discharge from hospital on 4/1/08.  Immediate pain at site of injection.  In the early hours of the morning of 4/2/08 blood pressure of 78/67, 94/67 and 109/76. Temp of 100.7 and 100.3.  At 8:40 am, BP of 97/62; 9:08 BP of 88/57.  Took to ER, followed by admission to hospital.  Bursa sac full of fluid, dehydration, low BP, fever, high creatinine level,elbow fully inflamed with pain from shoulder to the tips of fingers.  Arm had shown no inflammation at 3am on April 2, but fully inflamed at 8:30 am, indicating cellulitis.  Diagnosed with ATN and cellulitis. 11/23/09 Medical records received for dates 4/2/08 to 4/12/08. DX: LUE cellulitis vs acute vaccine reaction. Pt admitted for abdominal pain/bloated sx. Multiple diagnostics performed, upon dc/ pt given pneumovax left arm, pt. states immed at time of vax noted pain and increase erythema of next several hours at home. Pt states had weakness and malaise then fever, confusion, low BP, and decreased ROM. Pt went to ER. Sed rate 35(H), CRP 12.48(H). Pt admitted tx IV abx for cellulitis of left arm/elbow. Assessment: left elbow pain, limited ROM noted, erythema from left shoulder to elbow. Pt. dc in stable condition. Pt readmitted on 4/10/08 to 4/12/08 for  nausea and retching. DX: dehydration.  ICD9 codes: 999.39, 584.5, 682.3, 780.79,693.0, 780.6, 719.42, 401.9, 458.9, 276.50, 276.51, 584.9, 787.01.
Area below injection site red, swollen,  very itchy, and warm to touch.  Swollen area about 5 inches by 4 inches.  Driving me crazy so itchy.
From telephone contact received at manufacturer, on 09/24/2002, it was reported that a 55-year-old male pt, was vaccinated with TD ADS Adult (lot #U0736AA, expiration date 05/06/2004) on 09/18/2002. The pt was seen by a physician on 09/21/2002 with a cellulitis of the shoulder. It was not reported whether the pt recovered from this adverse event.
Patient became febrile w/ fever of 103 F axillary within 24 hours of vaccine administration. Fever was controlled with cool baths and infant Tylenol and fever brought down to 99.5 F axillary by next day. Patient otherwise fine. Mother told to take temperature between Tylenol doses and to give Tylenol if temp over 100 F. Instructed to call back if fever persisted past 48-72 hours.
Injection site on left arm of resident turned red, warm, and firm. Reaction began two days after injection.  Chief nurse directed resident to contact their Primary Care Provider.
Wheezing; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Wheezing) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002F21A and 006D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced WHEEZING (Wheezing). At the time of the report, WHEEZING (Wheezing) had resolved.            No concomitant product use was provided by the reporter. The patient woke up in the night wheezing. The patient walked up and down the hall a few times and it went away.   No treatment medications were reported.
Developed a rash 2 days after - blistery rash. Started on arms, then chest, and spread to rest of the body.  Was itchy, the blisters scabbed over and now is getting more blisters again. Rash was stinging and was not able to even sleep. Seen by CNP and then a few days later went to the ER -received antibiotics and steroids.
Patient died sometime between Sunday evening, April 4 and Monday morning, April 5. I looked at the browser history in her cellphone and on the night of April 4, she googled "Heart attack symptoms in women" and "Moderna vaccination side effects." I think she didn't go to the doctor because she figured her symptoms were related to her vaccine -- even though it had been a week.   I wanted to report her death because I don't trust her doctor to do it. It took him two weeks and a call from me to complain before he signed her death certificate. He listed April 9, 2021 as the official date of death because that's when she was found, even though the deputy coroner told me she died on either the 4th or the 5th.
42 year old African American male states that his "skin has been discolored since last vaccination and wants to make sure it is not infected."   States that he was going to take his 3rd Anthrax Vaccine but was concerned about the previous vaccination site and was referred to the immunization clinic.  Also states that after receiving his second Anthrax Vaccine he started noticing wrist and finger joint aches.  States that his knuckles were so painful that he felt like crying.  Rates joint pain as a 10 on pain scale 0-10.  States that now he rates the pain as a 3-4 on pain scale 0-10.  Denies any associated symptoms. States that he was planning on going to sick call for joint pain. Denies any repetitive motion or trauma.  Reports weight lifting 5 out 7 days a week.
Headache, body ache, fatigue Did not seek medical attention  Lasted 24 hours w
3RD DOSE OF THE PFIZER VACCINE RECEIVED 4/4/2022. SHE WAS GIVEN THE 2ND BOOSTER IN ERROR TODAY. NO SE/ADR'S NOTED AT THIS TIME. MD NOTIFIED WITH NNO.
She has not been feeling right; she does not feel normal/ Fuzzy head; she feels very sick; She feels like her symptoms from her thyroid have like over taken her body; She feel like everything is aching, everything hurt; everything burns; It's hard for her to have her balance; This is a spontaneous report from a contactable consumer. An 82-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6202), via an unspecified route of administration at the age of 82 years, on 07Mar2021 at a SINGLE DOSE for covid-19 immunisation. Medical history included ongoing thyroid disorder. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for covid-19 immunization. The reporter stated, "I am a daughter for patient who got the Pfizer shot". On an unspecified date, the reporter further stated, "I am calling in regards to my mother, she is 82 years old and she got her second vaccine on the 7th, on the Sunday and ever since then, she has not been feeling right, she has a condition where she has too many antibodies for her thyroid, but the first shot she got she felt fine after. This time she feels like her symptoms from her thyroid have like over taken her body and she feels very sick, she does not feel normal, she feel like everything is aching, everything  burns, everything hurt, her head is fuzzy, it's hard for her to have her balance, it's only after she got the second shot she started feeling like that, the next day Monday, so we don't know what to do because we don't know how long will this last, she feels like she is dying, which is lot for my mom to say because she can take some pain, so I want to know the way this functions." The outcome of the events was unknown.
got first dose / on 09/08/2020 never got the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (as 1st dose received on 9th August 2020 X3P72 and expiry date 7th November 2022').   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional details were reported as follows: The age at vaccination was not applicable for this report. The patient received first dose of Shingrix at primary reporter's facility. Till the time of reporting, the patient never received 2nd dose of Shingrix,which led to incomplete course of vaccination. The pharmacist inquired for revaccination. The reporter consented to follow up.
Patient received dose 1 of the Pfizer COVID vaccine on 1/7/2022. The patient arrived at the vaccine POD on 1/28/2022 for his 2nd dose reporting that, 2 days post-injection, he started experiencing frequent migraines and intermittent sensation of tachycardia while at rest. Patient reports he followed up with his provider who did not make a recommendation for the 2nd dose. The patient reported no allergies, no medical conditions, he takes Aleve as needed for migraines. RN notified PHN who followed up with the clinical project coordinators at 1442. At 1451, PHN received approval for patient to received 2nd dose of Pfizer COVID vaccine per Dr  and to follow up with provider regarding migraines. PHN relayed information to patient. The patient received dose2 of the Pfizer COVID vaccine at approximately 1510 (lot FK9729).
Tdap (Adacel) vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger; Tdap (Adacel) vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger; Initial information received on 03-Aug-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient and reporter reported Tdap [Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (lot number: U7869AA) (with an unknown strength, expiry date) via unknown route in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date, the reporter reported Tdap [Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger (skin laceration) (syringe issue) (unknown latency).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the reported events.  Outcome: Unknown the reported event
A report was received from a consumer on 10/11/02, concerning a 28 year old female who experienced a painful, swollen and red hot elbow which was considered medically significant, 2 hours after receiving Fluvirin on 10/9/02. The vaccinee reported that she had no history of joint pain. On 10/9/02, the vaccinee received Fluvirin in the deltoid region of her arm. Her arm became painful after 2 hours, and continued to be painful, red and hot despite the application of ice packs to the area. The area also began to swell, which made it difficult for her to bend her arm. The vaccinee attended an ER  where she was prescribed an anti-inflammatory agent. By 10/11/02, the swelling had reduced but she was still experiencing pain with the area remaining red and hot. The vaccinee was planning to see her doctor again on 10/12/02. The vaccinee had not recovered at the time of reporting. The reporter has assessed the relationship of study medication to the event as possible. The vaccinee has not provided details of her physician.  Follow up on 01/29/2003: "A report was received from the consumer indicating that the injection site was very painful for 24 hours following vaccination and that the left elbow was swollen with fluid.  The vaccinee received ER treatment with steroids on 10/12/2002.  Symptoms were reported as resolved on the 10/15/2002 after 48 hours treatment with steroids."
Developed shingles within 24 hours of dose two of  Pfizer vaccine. Within 9 hours of vaccine was bed ridden for 3 days with high fever, extreme pins and needles chills, dizziness and welts covering the back left side of my body. Most welts disappeared after the fever broke except a  severe cluster of blisters that developed on my left back to buttocks that remain now and have been diagnosed by my primary doctor as shingles. I am still experiencing severe nerve pain  and the shingles have crusted over and are incredibly sore. I have never had shingles ever before.
Woke up shaking, headache, hurting all over.  Lasted about an hour.  Feeling tired still on day 6.  Day 4 one cold sore started, Day 5, two more cold sores.
EXPIRED PRODUCT ADMINISTERED; This spontaneous report received from a pharmacist concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 220A21A expiry: 01-MAR-2022) dose was not reported, administered on 12-MAR-2022 for covid-19 prophylaxis. The drug was associated with Medication error. No concomitant medications were reported.  On 12-MAR-2022, the patient experienced expired product administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired product administered was not reported. This report was non-serious.
Bad headache; Chills; Body aches; Tiredness; Arm sore at injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200), via an unspecified route of administration in the left arm on 12Feb2021 at 14:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic to LEXAPRO. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), selenium sulphide (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Feb2021 at 03:30, the patient experienced bad headache, chills, body aches, tiredness and arm sore at the injection site. The patient did not receive any treatment for the events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events bad headache, chills, body aches, tiredness and arm sore at the injection site were resolved on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Starting the day after receiving the vaccine, I had every single side effect that was listed for the vaccine. I was unable to move my arm and I was miserable. This lasted for 3 days. It was so bad that I wanted to avoid the 2nd dose.